Novel aphidicolin-inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene

Genes Chromosomes and Cancer

Volumn 46, Issue 11, 2007, Pages 991-999

  Sawińska, Małgorzata ^a   Schmitt, Jens Guido ^a   Sagulenko, Evgeny ^a   Westermann, Frank ^a   Schwab, Manfred ^a   Savelyeva, Larissa ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; BRCA2 PROTEIN;

ARTICLE; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; CHROMOSOMAL LOCALIZATION; CHROMOSOME 9P; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME STRUCTURE; CONTROLLED STUDY; DATA BASE; DNA SEQUENCE; DNA SYNTHESIS INHIBITION; FRA9G GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; METAPHASE; NORMAL HUMAN; PRIORITY JOURNAL;

APHIDICOLIN; CHROMOSOME FRAGILE SITES; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; OPEN READING FRAMES; TRANSCRIPTION, GENETIC;

EID: 34848909041     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20484     Document Type: Article

References (46)

1. Arlt MF, Durkin SG, Ragland RL, Glover TW 2006. Common fragile sites as targets for chromosome rearrangements. DNA Repair 5:1126-1135.
2. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ. Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM. 2001. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 61:8068-8073.
3. Bester AC, Schwartz M, Schmidt M, Garrigue A, Hacein-Bey-Abina S, Cavazzana-Calvo M, Ben-Porat N, Von Kalle C, Fischer A, Kerem B. 2006. Fragile sites are preferential targets for integrations of MLV vectors in gene therapy. Gene Ther 13:1057-1059.
4. Büttel I, Fechter A, Schwab M. 2004. Common fragile sites and cancer: Targeted cloning by insertional mutagenesis. Ann NY Acad Sci 1028:14-27.
5. Christ LA, Crowe CA, Micale MA, Conroy JM, Schwartz S. 1999. Chromosome breakage hotspots and delineation of the critical region for the 9p-deletion syndrome. Am J Hum Genet 65:1387-1395.
6. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215-225.
7. Craig-Holmes AP, Strong LC, Goodacre A, Pathak S. 1987. Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures. Hum Genet 76:134-137.
8. Curatolo A, Limongi ZM, Pelliccia F, Rocchi A. 2007. Molecular characterization of the human common fragile site FRA1H. Genes Chromosomes Cancer 46:487-493.
9. Debacker K, Winnepenninckx B, Ben-Porat N, FitzPatrick D, Van Luijk R, Scheers S, Kerem B, Frank Kooy R. 2007. FRA18C: A new aphidicolin-inducible fragile site on chromosome 18q22, possibly associated with in vivo chromosome breakage. J Med Genet 44:347-352.
10. Debatisse M, Coquelle A, Toledo F, Buttin G. 1998. Gene amplification mechanisms: The role of fragile sites. Recent Results Cancer Res 154:216-226.
11. Denison SR, Simper RK, Greenbaum IF. 2003. How common are common fragile sites in humans: Interindividual variation in the distribution of aphidicolin-induced fragile sites. Cytogenet Genome Res 101:8-16.
12. Fechter A, Buettel I, Kuehnel E, Savelyeva L, Schwab M. 2007a. Common fragile site FRA11G and rare fragile site FRA11B at 11qq23.3 encompass distinct genomic regions. Genes Chromosomes Cancer 46:98-106.
13. Fechter A, Buettel I, Kuehnel E, Schwab M, Savelyeva L. 2007b. Cloning of genetically tagged chromosome break sequences reveals new fragile sites at 6p21 and 13q22. Int J Cancer 120:2359-2367.
14. Glover TW. 2006. Common fragile sites. Cancer Lett 28:4-12.
15. Glover TW, Berger C, Coyle J, Echo B. 1984. DNA polymerase α inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Gen 67:136-142.
16. Gudmundsdottir K, Ashworth A. 2006. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25:5864-5874.
17. Helmrich A, Stout-Weider K, Hermann K, Schrock E, Heiden T. 2006. Common fragile sites are conserver features of human and mouse chromosomes and relate to large active genes. Genome Res 16:1222-1230.
18. Helmrich A, Stout-Weider K, Matthaei A, Hermann K, Heiden T, Schrock E. 2007. Identification of the human/mouse syntenic common fragile site FRA7K/Fra12C1 - Relation of FRA7K and other human common fragile sites on chromosome 7 to evolutionary breakpoints. Int J Cancer 120:48-54.
19. Henegariu O, Bray-Ward P, Ward DC. 2000. Custom fluorescent-nucleotide synthesis as an alternative method for nucleic acid labeling. Nat Biotechnol 18:345-348.
20. Hormozian F, Schmitt JG, Sagulenko E, Schwab M, Savelyeva L. 2006. FRA1E common fragile site breaks map within a 370 kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD). Cancer Lett 246:82-91.
21. Huebner K, Croce CM. 2001. FRA3B and other common fragile sites: The weakest links. Nat Rev Cancer 1:214-221.
22. Jahee FS, Johnson D, Alonso LG, Cavalcanti DP, de Sa Moreira E, Alberto FL, Kok F, Kim C, Wall SA, Jabs EW, Boyadjiev SA, Wilkie AO, Passos-Bueno MR. 2005. Molecular screening for microdeletions at 9p22-p24 and 11q23-q24 in a large cohort of patients with trigonocephaly. Clin Genet 67:503-510.
23. Mangelsdorf M, Ried K, Woollatt E, Dayan S, Eyre H, Finnis M, Hobson L, Nancarrow J, Venter D, Baker E, Richards RI. 2000. Chromosomal fragile sites FRA16D and DNA instability in cancer. Cancer Res 60:1683-1689.
24. Mimori K, Druck T, Inoue H, Alder H, Berk L, Mori M, Huebner K, Croce CM. 1999. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc Natl Acad Sci USA 96:7456-7461.
25. Mitelman F, Johansson B, Mertens F. 2007. Mitelman Database of Chromosome Aberrations in Cancer. Available at http://cgap.nci.nih.gov/Chromosomes/ Mitelman.
26. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K. 1996. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
27. Popescu NC. 2003. Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett 192:1-17.
28. Rao PN, Heerema NA, Palmer CG. 1988. Fragile sites induced by FUdR, caffeine, and aphidicolin. Their frequency, distribution, and analysis. Hum Genet 78:21-26.
29. Reshmi SC, Huang X, Schoppy DW, Black RC, Saunders WS, Smith DI, Gollin SM. 2007. Relationship between FRA11F and 11q13 gene amplification in oral cancer. Genes Chromosomes Cancer 46:143-154.
30. Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A, Venter D, Baker E, Richards RI. 2000. Common chromosomal fragile site FRA16D sequence: Identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 9:1651-1663.
31. Rozier L, El-Achkar E, Apiou F, Debatisse M. 2004. Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: Possible association with an inherited disease and cancer. Oncogene 23:6872-6880.
32. Savelyeva L, Claas A, Matzner I, Schlag P, Hofmann W, Scherneck S, Weber B, Schwab M. 2001. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers. Cancer Res 61:5179-5185.
33. Savelyeva L, Sagulenko E, Schmitt JG, Schwab M. 2006a. The neurobeachin gene spans the common fragile site FRA13A. Hum Genet 118:551-558.
34. Savelyeva L, Sagulenko E, Schmitt JG, Schwab M. 2006b. Low-frequency common fragile sites: Link to neuropsychiatric disorders? Cancer Lett 232:58-69.
35. Schwartz M, Zlotorynski E, Goldberg M, Ozeri E, Rahat A, le Sage C, Chen BP, Chen DJ, Agami R, Kerem B. 2005. Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes Dev 19:2715-2726.
36. Schwartz M, Zlotorynski E, Kerem B. 2006. The molecular basis of common and rare fragile sites. Cancer Lett 232:13-26.
37. Shivji MK, Venkitaraman AR. 2004. DNA recombination, chromosomal stability and carcinogenesis: Insights into the role of BRCA2. DNA Repair 3:835-843.
38. Smeets DF, Scheres JM, Hustinx TW. 1986. The most common fragile site in man is 3p14. Hum Gen 72:215-220.
39. Smit AF. 1999. Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr Opin Genet Dev 9:657-663.
40. Smith DI, Zhu Y, McAvoy S, Kuhn R. 2006. Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett 232:48-57.
41. Smith DI, McAvoy S, Zhu Y, Perez DS. 2007. Large common fragile site genes and cancer. Semin Cancer Biol 17:31-41.
42. Sutherland GR. 1979. Heritable fragile sites on human chromosomes I. Factors affecting expression in lymphocyte culture. Am J Hum Genet 31:125-135.
43. Sutherland GR. 2003. Rare fragile sites. Cytogenet Genome Res 100:77-84.
44. Tedeschi B, Vernole P, Sanna ML, Nicoletti B. 1992. Population cytogenetics of aphidicolin-induced fragile sites. Hum Genet 89:543-547.
45. Warren M, Lord CJ, Masabanda J, Griffin D, Ashworth A. 2003. Phenotypic effects of heterozygosity for a BRCA2 mutation. Hum Mol Genet 12:2645-2656.
46. Yunis JJ, Soreng AL. 1984. Constitutive fragile sites and cancer. Science 226:1199-1204.